Vaccines activate suitable immune responses to fight against diseases but can possess
limitations such as compromised efficacy and immunogenic responses, poor stability, and …

Nanovaccine‐based immunotherapy (NBI) has received greater attention recently for its
potential to prime tumor‐specific immunity and establish a long‐term immune memory that …

Cancer immunotherapy has emerged as a promising strategy for the treatment of many
forms of cancer by stimulating body's own immune system. This therapy not only eradicates …

Supramolecular peptide assemblies with specific motifs have the advantages of high
immunogenicity, regulated immune response, and increased multiple functions in improving …

The global menace of cancer has led to an increased death toll in recent years. The constant
evolution of cancer therapeutics with novel delivery systems has paved the way for …

In personalized cancer immunotherapy, developing an effective neoantigen nanovaccine
with high immunogenicity is a significant challenge. Traditional nanovaccine delivery …

The combination of peptides and nanoparticles in cancer therapy has shown synergistic
results. Nanoparticle functionalization with peptides can increase their targeting ability …

Nanovaccines have gathered significant attention for their potential to elicit tumor-specific
immunological responses. Despite notable progress in tumor immunotherapy, nanovaccines …

Cancer has been a serious health hazard to the people all over the world with its high
incidence and horrible mortality. In recent years, tumor vaccines in immunotherapy have …

Dendritic cells (DCs) can process the antigens of cancer vaccine and thus stimulate the
CD8+ T cells to recognize and kill the tumor cells that express these antigens. However, lack …